Methods for Ultrasound Screening of Cardiovascular Diseases in Type 2 Diabetic Patients

1. WH Organization. Diabetes. Fact Sheet N312 2014. http://www.who.int/mediacentre/factsheets/fs312/en/%5D. Accessed Nov 2014.Search in Google Scholar

2. World Health Organization (WHO) Consultation. Definition and diagnosis of diabetes and intermediate hyperglycaemia. 2006, http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdfSearch in Google Scholar

3. The DECODE Study Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003;26:688-696.10.2337/diacare.26.3.688Open DOISearch in Google Scholar

4. Norhammar A, Tenerz Å, Nilsson G, et al . Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus. A prospective study. Lancet 2002; 359: 2140-2144.10.1016/S0140-6736(02)09089-XSearch in Google Scholar

5. Lang R, Biering M, Devereux RB et al. Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjuction with the European Association of Echocardiography, a Branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18(12): 1440-1463.10.1016/j.echo.2005.10.00516376782Search in Google Scholar

6. Popescu BA, Carmen CB, Carmen G. Echocardiographic ssessment of diastolic heart failure. European Cardiology 2010, 6(3): 13-17.10.15420/ecr.2010.6.3.13Open DOISearch in Google Scholar

7. Liu JH, Chen Y, Yuen M et al. Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2016;15:22. doi: 10.1186/s12933-016-0333-5.Search in Google Scholar

8. Mitrovska S, Lazeska B. Contemporary Echocardiographic Techniques in Early Detection of Diabetic Cardiomyopathy. J Cardiol Curr Res 2014; 1(5): 00025.10.15406/jccr.2014.01.00025Search in Google Scholar

9. Boyer J, Thanigaraj S, Schechtman KB, Perez JE (2004) Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93(7): 870-875.10.1016/j.amjcard.2003.12.02615050491Open DOISearch in Google Scholar

10. Zahiti BF, Gorani DR, Gashi FB, et al. Left Ventricular Diastolic Dysfunction in Asymptomatic Type 2 Diabetic Patients: Detection and Evaluation by Tissue Doppler Imaging. Acta Informatica Medica 2013;21(2):120-123.10.5455/aim.2013.21.120-122Search in Google Scholar

11. Hölscher ME, Bode C, Bugger H. Diabetic Cardiomyopathy: Does the Type of Diabetes Matter? Int J Mol Sci. 2016 Dec 18;17(12) pii: E2136.10.3390/ijms17122136518793627999359Open DOISearch in Google Scholar

12. An D., Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 291 2006:H1489-H1506.10.1152/ajpheart.00278.200616751293Search in Google Scholar

13. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058-70.10.1161/CIRCRESAHA.110.223545299692221030723Search in Google Scholar

14. Bergerot C, Davidsen ES, Amaz C et al. Diastolic function deterioration in type 2 diabetes mellitus: predictive factors over a 3-year follow-up. Eur Heart J Cardiovasc Imaging. 2017 Feb 6. doi: 10.1093/ehjci/jew331.Search in Google Scholar

15. Fontes-Carvalho R, Ladeiras-Lopes R, Bettencourt P et al. Diastolic dysfunction in the diabetic continuum: association ith insulin resistance, metabolic syndrome and type 2 diabetes. Cardiovasc Diabetol. 2015 Jan 13;14:4. doi: 10.1186/s12933-014-0168-x.Search in Google Scholar

16. Paneni F, Gregori M, Tocci G et al. Do diabetes, metabolic syndrome or their association equally affect biventricular function? A tissue Doppler study. Hypertens Res. 2013 Jan;36(1):36-42.10.1038/hr.2012.13722951523Open DOISearch in Google Scholar

17. Ofstad AP, Urheim S, Dalen H et al. Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls. J Diabetes. 2015 Nov;7(6):779-90.10.1111/1753-0407.1223925350248Search in Google Scholar

18. De Jong KA, Czeczor JK, Sithara S et al. Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study. Cardiovasc Diabetol. 2017 Feb 8;16(1):21.10.1186/s12933-017-0504-z529977628178970Search in Google Scholar

19. Jørgensen PG, Jensen MT, Mogelvang R et al. Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics. Diab Vasc Dis Res. 2016 Sep;13(5):321-30.10.1177/147916411664558327208801Search in Google Scholar

20. Rossi A, Zoppini G, Benfari G et al. Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes. Am J Med. 2017 Jan;130(1):70-76.e1.10.1016/j.amjmed.2016.07.01627555095Search in Google Scholar

21. Blomstrand P, Engvall M, Festin K et al. Left ventricular diastolic function, assessed by echocardiography and tissue Doppler imaging, is a strong predictor of cardiovascular events, superior to global left ventricular longitudinal strain, in patients with type 2 diabetes. Eur Heart J Cardiovasc Imaging. 2015;16(9):1000-7.10.1093/ehjci/jev02725750201Search in Google Scholar

22. Naqvi TZ, Lee MS. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC Cardiovasc Imaging. 2014;7(10):1025-38.10.1016/j.jcmg.2013.11.01425051948Search in Google Scholar

23. Niu L, Zhang Y, Qian M et al. Impact of multiple cardiovascular risk factors on carotid intima-media thickness and elasticity. PLoS One. 2013 2;8(7):e67809.10.1371/journal.pone.0067809369947423844099Search in Google Scholar

24. Baldassarre D, Hamsten A, Veglia F et al. IMPROVE Study Group. Measurements of carotid intima-media thickness and of interadventitia common carotid diameter improve prediction of cardiovascular events: results of the IMPROVE (Carotid Intima Media Thickness [IMT] and IMTProgression as Predictors of Vascular Events in a High Risk European Population) study. J Am Coll Cardiol. 2012 Oct 16;60(16):1489-99.10.1016/j.jacc.2012.06.03422999719Search in Google Scholar

25. Plasencia Martínez JM, Garcia Santos JM, Paredes Martinez ML, Pastor AM. Carotid intima-media thickness and hemodynamic parameters: reproducibility of manual measurements with Doppler ultrasound. Med Ultrason. 2015;17(2):167-74.10.11152/mu.2013.2066.172.ci-m26052566Search in Google Scholar

26. Touboul PJ, Hennerici MG, Meairs S et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006- 2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis. 2012;34(4):290-6.10.1159/000343145376079123128470Search in Google Scholar

27. Gállego Pérez-Larraya J, Irimia P, Martínez-Vila E et al. The influence of obesity on the assessment of carotid intima-media thickness. J Clin Ultrasound. 2012 Oct;40(8):479-85.10.1002/jcu.2191622508361Search in Google Scholar

28. Badeĭnikova KK, Mazaev AP, Toguzova ZA et al. [Detection of early markers of atherosclerosis in men with various levels of risk of cardiovascular complications]. Kardiologiia. 2014;54(6):35-9.10.18565/cardio.2014.6.35-3925178075Search in Google Scholar

29. Silvestrini M, Altamura C, Cerqua R et al. Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis. J Cereb Blood Flow Metab. 2013;33(4):619-24.10.1038/jcbfm.2013.5361840123361391Search in Google Scholar

30. Lubas A, Kade G, Niemczyk S. Renal resistive index as a marker of vascular damage in cardiovascular diseases. Int Urol Nephrol. 2014;46(2):395-402.10.1007/s11255-013-0528-6393217123959401Open DOISearch in Google Scholar

31. Kawai T, Kamide K, Onishi M et al. Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis. Nephrol Dial Transplant. 2011;26(10):3256-62.10.1093/ndt/gfr05421372256Search in Google Scholar

32. Bruno RM, Daghini E, Landini L, et al. Dynamic evaluation ofrenal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes. Diabetologia. 2011;54:2430-2439.10.1007/s00125-011-2148-y21499674Open DOISearch in Google Scholar

33. Mancini M, Masulli M, Liuzzi R et al. Renal duplex sonographic evaluation of type 2 diabetic patients. J Ultrasound Med. 2013;32(6):1033-40.10.7863/ultra.32.6.103323716525Search in Google Scholar

34. MacIsaac RJ, Thomas MC, Panagiotopoulos S et al. Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes. Cardiovasc Diabetol. 2008 23;7:15. doi: 10.1186/1475-2840-7-15.Search in Google Scholar

35. Kinouchi M, Aihara K, Fujinaka Y et al. Diabetic conditions differentially affect the endothelial function, arterial stiffness and carotid atherosclerosis. J Atheroscler Thromb. 2014;21(5):486-500.10.5551/jat.2083424401746Open DOISearch in Google Scholar

36. Staub D, Meyerhans A, Bundi B et al. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness. Stroke. 2006;37(3):800-5.10.1161/01.STR.0000202589.47401.c616439703Open DOISearch in Google Scholar

37. Chung H, Jung YH, Kim KH et al. Carotid Artery End- Diastolic Velocity and Future Cerebro-Cardiovascular Events in Asymptomatic High Risk Patients. Korean Circ J. 2016;46(1):72-8.10.4070/kcj.2016.46.1.72472085226798388Search in Google Scholar